• Pragmatic Clinical Trials Need Their Own Set Of Rules

    Clinical Research News | Pragmatic clinical trials (PCTs) require a more nuanced playbook than traditional explanatory studies when it comes to informed consent and respect for individuals. New models for engagement, transparency, and accountability will also be needed to accommodate the scale and heterogeneity of PCTs.

    May 12, 2021
  • New ‘Research Data Mart’ To Help Academic Sites Track Trial Performance

    Clinical Research News | A university’s ability to conduct clinical trials with speed and efficiency has become a key consideration of the National Institutes of Health (NIH) when doling out grants, so the Medical University of South Carolina has created a digital platform called Research Integrated Network of Systems (RINS) to generate the kind of performance benchmarks that can help keep institutions in the running.

    May 10, 2021
  • Intelligent Technology: Impacting the Future of Clinical Research

    Clinical Research News | Today’s clinical trial landscape is incredibly complex to navigate. A prevailing issue is inefficiency—relying on years of approved and proven SOPs that can result in expensive delays and increased burdens for patients, sites and sponsors. The good news is disruptive technologies—specifically artificial intelligence—are tangibly resolving challenges inherent to the clinical trial process.

    May 6, 2021
  • ERT and Bioclinica Close Merger, Parexel and Veeva Collaborate, More

    Clinical Research News | Mergers and strategic collaborations link data from devices and sensors, streamline research workflows, and aim to accelerate clinical trials. Plus, updated CTMSs, expanded CROs, and more new products and updates from around the industry.

    May 3, 2021
  • Why Imaging Biomarkers Represent the Next Generation of Personalized Drug Development

    Clinical Research News | Imaging biomarkers, which are generated through the science of radiomics (think: advanced imaging analytics), are likely to play in the future of personalized drug development. Today, private industry and academia are collaborating on research to discover and develop new imaging biomarkers to add a new layer to the personalization of medicine.

    Apr 30, 2021
  • Seqster’s Series A, Investments in Digital Trials, and Virtual Care Delivery

    Clinical Research News | Medable nets cash to deliver decentralized trials; more money for telemedicine and telehealth delivery, investments in healthcare data platforms, and more.

    Apr 29, 2021
  • Medable: Real-World Evidence Needed To Address Health Disparities

    Clinical Research News | The pandemic has served to highlight the value of real-world evidence (RWE) in personalizing the delivery of care and potentially reducing disparities in access to treatment options, including clinical studies. To explore this “new frontier,” Medable has contracted with Kaiser Permanente to develop mobile apps designed to capture insights from informal caregivers, and digital biomarkers from wearable devices with patients, in fully decentralized trials.

    Apr 26, 2021
  • Biomarker Discovery Reveals Role of Lipids in Age-Related Pathologies

    Clinical Research News | Senescent cells can be good or bad actors when it comes to human health, but their steady accumulation with aging has adverse consequences that pharmaceutical companies are keen on reversing. Determining if a senolytic drug is working in the human body is a tough proposition, however, since the testing process often involves a biopsy and waiting long periods of time to determine whether a pathology has been ameliorated.

    Apr 21, 2021
  • How to Make Translations Work for Everyone

    Clinical Research News | When conducting a clinical trial on a global scale, sponsors assume a certain amount of risk in addition to significant management challenges, many of which can be attributed to communication. For this reason, comprehensive translation strategies are important to consider prior to moving forward with a clinical trial.

    Apr 19, 2021
  • Sanofi Reaping Rewards Of Site- And Patient-Centric Clinical Development

    Clinical Research News | Sanofi has succeeded in accelerating its clinical development timeline year over year, in large part by viewing patients as customers and key opinion leaders (KOLs), according to Victoria DiBiaso, vice president and regional head of the clinical studies unit in Asia Pacific, Eurasia, Middle East, and Africa. “What that means for patients is that we are developing meaningful healthcare solutions that are addressing unmet needs and we are doing it faster.”

    Apr 14, 2021
  • Patient Driven-Data: The Key to Improving the Health Ecosystem

    Clinical Research News | What are the benefits of Personal Health Records (PHRs) are, not just to patients, but to the wider health system? The most straightforward answer is this: patients who are engaged in their healthcare and understand their condition have better health outcomes. PHRs have a vital role to play in patient empowerment, effective clinical trials, and preventative and precision medicine around the world.

    Apr 13, 2021
  • Addressing Social Determinants Of Health To Improve Clinical Trial Diversity

    Clinical Research News | Health equality does not assure health equity, where the focus is on fixing root problems so access to tools and resources is possible across populations, according to Laurie Myers, global health literacy director at Merck.

    Apr 9, 2021